Abstract:Abstract Background Chemoresistance is emerging as a major barrier to successful treatment in acute myeloid leukemia (AML), and evasion of apoptosis is among the fundamental underlying mechanisms. Therefore, unraveling molecular networks that drive this process constitutes an urgent unmet need. Herein, we aim to characterize the role and molecular mechanism of the tumor necrosis factor ɑ-induced protein 8 (TNFAIP8), a novel anti-apoptotic molecule, in AML chemoresistance. Methods The expression levels of TNFAIP8 were assessed in AML patients and cell lines by RT-qPCR and western blots. The transcriptional regulation of TNFAIP8 was analyzed with luciferase reporter assay and ChIP followed by RT-qPCR. Functional experiments were conducted to evaluate the effects of TNFAIP8 on apoptosis, drug sensitivity and proliferation of AML cells. Potential effects of TNFAIP8 on the activation of extracellular signal-regulated kinase (ERK) pathway were detected by western blots. CoIP and P21-activated kinase (PAK) pull-down assay were performed to ascertain the upstream target. The overall effects of TNFAIP8 on AML were examined in murine models. Results Upregulated TNFAIP8 expression was first confirmed in human AML patients and cell lines. E74 like ETS transcription factor 1 (ELF1) was then identified to contribute to its aberrant expression. Through manipulating TNFAIP8 expression, we described its role in protecting AML cells from apoptosis induced by chemotherapeutic agents and in promoting drug resistance. Notably, the leukemia-promoting action of TNFAIP8 was mediated by sustaining activity of the ERK signaling pathway, through an interaction with Rac family small GTPase 1 (Rac1). In addition, in vivo experiments confirmed that TNFAIP8 suppression lowered leukemia infiltration and improved survival. Conclusion Our data provide a molecular basis for the role of TNFAIP8 in chemoresistance and progression of AML and highlight the unique function of TNFAIP8 as an attractive therapeutic target.

Advances in Clinical Significance and Its Potential Mechanism of Tumor Necrosis Factor-α Induced Protein-8

Tumor Necrosis Factor-Alpha Induced Protein 8: Pathophysiology, Clinical Significance, And Regulatory Mechanism

Research progress of tumor necrosis factor-α induced protein 8 family

The tumor necrosis factor-alpha-induced protein 8 family in immune homeostasis and inflammatory cancer diseases.

Research Progress of Relationship between TNFAIP8 Protein Family and Tumor Development

Current research status of TNFAIP8 in tumours and other inflammatory conditions (Review)

Oncogenic Role of Tumor Necrosis Factor α-Induced Protein 8 (TNFAIP8)

The Expression of TNFAIP8 in Gastric Cancer and Its Clinical Significance

Crucial Roles of TNFAIP8 Protein in Regulating Apoptosis Andlisteriainfection

Update in Immune Regulatory Pathway of Tumor Necrosis Factor-Α-induced Protein 8-Like 2

Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression

Expression of tumor necrosis factor α-induced protein 8 is upregulated in human gastric cancer and regulates cell proliferation, invasion and migration.

TNFAIP8 Promotes Cell Growth by Regulating the Hippo Pathway in Epithelial Ovarian Cancer.

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1

Progresse on Tumor Necrosis Factor-α

Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy.

Research Advance in TNF Related Apoptosis Inducing Ligand

Recent Advances for Research on Anti-Tumor Effects of TNF-related Apoptosis-Inducing Ligand

Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer

The Investigation of the Relationship Between Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Tumor Therapy

Regulatory Roles of Tumor Necrosis Factor-α-Induced Protein 8 Like-Protein 2 in Inflammation, Immunity and Cancers: A Review